Pediatrix director granted 472 restricted shares

Newman Kurt Douglas reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Newman Kurt Douglas reported acquisition or exercise transactions in this Form 4 filing.

Pediatrix Medical Group director Kurt Douglas Newman received a grant of 472 shares of common stock as a restricted stock award under the company’s Second Amended and Restated 2008 Incentive Compensation Plan. The restricted shares will vest on May 7, 2027, bringing his directly held common stock to 17,405 shares after the award.

Insider Trade Summary

Grant/Award: 472 shares

Grant/Award 1 txn

Insider Newman Kurt Douglas

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	472	$26.50	$13K

Holdings After Transaction: Common Stock — 17,405 shares (Direct)

Footnotes (1)

1. F1. Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Key Figures

Restricted shares granted: 472 shares Grant price per share: $26.5000 per share Shares held after transaction: 17,405 shares +1 more

4 metrics

Restricted shares granted 472 shares Grant of common stock reported with transaction code A

Grant price per share $26.5000 per share Reported transaction price for the restricted stock award

Shares held after transaction 17,405 shares Total direct common stock holdings following the award

Vesting date May 7, 2027 Date on which the 472 restricted shares will vest

Key Terms

Restricted shares, Second Amended and Restated 2008 Incentive Compensation Plan, vesting, Grant, award, or other acquisition

4 terms

Restricted shares financial

"Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Second Amended and Restated 2008 Incentive Compensation Plan financial

"granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan"

vesting financial

"Shares will vest on May 7, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Grant, award, or other acquisition financial

"transaction code description Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Pediatrix Medical Group (MD) director Kurt Douglas Newman report on this Form 4?

Kurt Douglas Newman reported a grant of 472 restricted shares of Pediatrix Medical Group common stock. The award was made under the company’s 2008 Incentive Compensation Plan and increases his direct holdings to 17,405 shares after the transaction.

What type of transaction was reported by Kurt Douglas Newman for MD?

The filing shows a grant or award acquisition (code A) of common stock, not an open-market trade. He received 472 restricted shares as equity compensation rather than purchasing or selling shares in the market.

When do Kurt Douglas Newman’s restricted Pediatrix (MD) shares vest?

The 472 restricted shares granted to Kurt Douglas Newman will vest on May 7, 2027. Until vesting, they remain subject to the terms and conditions of Pediatrix Medical Group’s Second Amended and Restated 2008 Incentive Compensation Plan.

How many Pediatrix Medical Group (MD) shares does Kurt Douglas Newman own after this grant?

Following the restricted stock grant, Kurt Douglas Newman directly holds 17,405 shares of Pediatrix Medical Group common stock. This total includes the newly granted 472 restricted shares reported in the Form 4 filing.

Was the Pediatrix (MD) Form 4 transaction part of a Rule 10b5-1 plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, and the footnote describes the transaction as restricted shares granted under the 2008 Incentive Compensation Plan, not trades executed under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Newman Kurt Douglas

(Last) (First) (Middle)

1301 CONCORD TERRACE

(Street)

SUNRISE FLORIDA 33323

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		A(1)		472	A	$26.5	17,405	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

	/s/ David Haddock, Attorney-in-Fact	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)